-CaMbinding site in TRPV1CT led to a more subtle phenotype of slowed and reduced TRPV1 desensitization. In summary, our results show that the TRPV1ARD is an important mediator of TRPV1 desensitization, whereas TRPV1CT has higher affinity for CaM and is likely involved in separate regula tory mechanisms.
Transient receptor potential (TRP) vanilloid 1 (TRPV1) is well recognized as a polymodal molecular pain re ceptor that responds to a wide range of stimuli includ ing noxious heat >43°C, chemical agonists, and protons (Caterina et al., 1997; Tominaga et al., 1998) . TRPV1 responses to these stimuli signal the exposure to ex treme temperature or tissue damage to elicit appropri ate protective mechanisms. TRPV1 is well characterized for its activation by capsaicin, a naturally occurring compound found in chili peppers (Caterina et al., 1997) . Prolonged activation of TRPV1 with capsaicin results in acute desensitization, where TRPV1 activity decreases during the course of stimulation. In contrast, repeated stimulation of TRPV1 results in tachyphy laxis, where TRPV1 activation decreases with successive stimulation followed by loss of response to any sub sequent stimuli. Abbreviations used in this paper: ARD, ankyrin repeat domain; CaM, calmodulin; CaMKK, CaMdependent kinase kinase; CT, C terminal; MARCKS, myristoylated alaninerich C kinase substrate; MBP, maltose binding protein; PIP 2 , phosphatidylinositol4,5bisphosphate; SEC, size exclusion chromatography; TRP, transient receptor potential; TRPV1, TRP vanilloid 1. TRPV1 belongs to the TRP superfamily of nonselec tive cation channels with high relative permeability for Ca 2+ (Caterina et al., 1997) . All TRP channels share a similar topology comprising six predicted helical trans membrane segments (S1-S6) and large N and Cterminal (CT) cytosolic regions for integrating cellular signaling with channel activity (Gaudet, 2008) . The Nterminal region of TRPV1 contains an ankyrin repeat domain (ARD), of which a structure is available . The cytoplasmic C terminus, of unknown struc ture, contains multiple sites for interactions with modu latory factors. TRPV1 functions as a tetramer, with S5-S6 forming the pore through which ion conduction occurs. Opening of TRPV1 after channel activation allows the influx of cations, including Ca 2+ , into the cell. The intracellular Ca 2+ concentration is kept as low as 10 7 M compared with a high external Ca 2+ concentra tion up to 10 3 M (Yamniuk and Vogel, 2004 Transient receptor potential (TRP) vanilloid 1 (TRPV1) is a molecular pain receptor belonging to the TRP super family of nonselective cation channels. As a polymodal receptor, TRPV1 responds to heat and a wide range of chemical stimuli. The influx of calcium after channel activation serves as a negative feedback mechanism leading to TRPV1 desensitization. The cellular calcium sensor calmodulin (CaM) likely participates in the desensitization of TRPV1. Two CaMbinding sites are identified in TRPV1: the Nterminal ankyrin repeat domain (ARD) and a short distal Cterminal (CT) segment. Here, we present the crystal structure of calciumbound CaM (Ca 2+ -CaM) in complex with the TRPV1CT segment, determined to 1.95Å resolution. The two lobes of Ca 2+ -CaM wrap around a helical TRPV1CT segment in an antiparallel orientation, and two hydrophobic anchors, W787 and L796, contact the Clobe and Nlobe of Ca 2+ -CaM, respectively. This structure is similar to canonical Ca 2+ -CaMpeptide com plexes, although TRPV1 contains no classical CaM recognition sequence motif. Using structural and mutational studies, we established the TRPV1 C terminus as a high affinity Ca 2+ -CaMbinding site in both the isolated TRPV1 C terminus and in fulllength TRPV1. Although a ternary complex of CaM, TRPV1ARD, and TRPV1CT had previ ously been postulated, we found no biochemical evidence of such a complex. In electrophysiology studies, muta tion of the Ca 2+ -CaMbinding site on TRPV1ARD abolished desensitization in response to repeated application of capsaicin, whereas mutation of the Ca within this region decreased the Ca 2+ -CaMbinding affinity of TRPV1CT (Grycova et al., 2008) . It is unclear how Ca 2+ -CaM participates in desensitization of TRPV1 through its putative CaMbinding sites. It has been pos tulated that Ca 2+ -CaM may bridge the two sites, leading to a closed channel .
Here, we present the first structural view of Ca
2+
-CaM in complex with the 35residue CaMbinding peptide from the TRPV1CT (TRPV1CT35: residues 767-801). Despite the absence of a classical CaM recognition motif, the complex is supported by hydrophobic anchors and electrostatic interactions similar to wellcharacterized Ca 2+ -CaM peptide complexes. Our in vitro binding stud ies revealed that the Clobe of Ca 2+ -CaM is the major de terminant of binding to either TRPV1CT or TRPV1ARD. We examined whether Ca 2+ -CaM can bridge contacts be tween TRPV1ARD and TRPV1CT35, but our results do not support such a ternary complex. We used mutations that disrupt Ca
-CaM binding at either TRPV1ARD (K155A) or TRPV1CT (W787A) to show that the W787A TRPV1 mutant is sufficient to disrupt the interaction of Ca 2+ -CaM with fulllength TRPV1, consistent with our in vitro observation that the TRPV1CT is a high affinity binding site, with K d = 5.4 ± 0.6 × 10 8 M. Finally, although the K155A mutation abolished tachyphylaxis, W787A caused slowed and reduced TRPV1 desensitization. In summary, the TRPV1ARD is crucial for desensitization, although it is unclear whether this is through a direct interaction with CaM, whereas TRPV1CT is the major CaM interaction site but plays only a minor role in the capsaicininduced desensitization we measured.
M A T E R I A L S A N D M E T H O D S

Expression vectors
The TRPV1CT regions TRPV1CT44; TRPV1CT35) were cloned into SacI and EcoRI sites of pMALC2 (New England Biolabs, Inc.) as Nterminal maltosebinding protein (MBP) fusions with a PreScission (GE Healthcare) protease site (LEVLFQGP). CaM Clobe (residues 76-148) was cloned into NdeI and BamHI sites of pET21a (EMD Millipore). Fulllength TRPV1 was expressed from pTracerCMV2 for electrophysiology or pCDNA3FLAG for pulldown assays. TRPV1 containing the glycosylation site mutation N604S (Rosenbaum et al., 2002) was cloned into NdeI and NotI sites of pCDNA3FLAG. pCDNA3FLAG was generated by ligating a short doublestranded oligonucleotide (5GATCACATATGG GATC  CGAATTCGTCGA CACTAGTGACGTCGCGGCCGCTGATT  ACAAGGATGACG AC GATAAGTGACTCGAG3 and 5GGCC C  TCGAGTCACTTATCGT CGTCATCCTTG TAATCAG CGGC C  GCGACGTCACTAGTGTCG ACGAA TTCG GAT CCCATATGT3) into the BamHI and NotI sites of pCDNA3 and mutating the NdeI site within the CMV promoter to TATATG. Cysteine mutants of CaM and TRPV1CT were introduced using QuikChange site directed mutagenesis (Agilent Technologies) and confirmed by DNA sequencing.
Protein purification
Purification of CaM and TRPV1ARD was performed as described previously (Drum et al., 2001; Lishko et al., 2007) . CaM Clobe, homeostasis is crucial for normal cell function (Han et al., 2007) , and continuous capsaicin activation of cells ex pressing TRPV1 or stimulation of TRPV1 with the po tent agonist resiniferatoxin results in severe cytotoxicity and cell death (Caterina et al., 1997; Karai et al., 2004) . Ca 2+ ions are involved in various cellular processes in cluding several Ca 2+ dependent desensitization mecha nisms identified for TRPV1. One is the Ca 2+ dependent recruitment of the calcineurin phosphatase to TRPV1 via a scaffolding protein, promoting the dephosphory lation and dampening of TRPV1 activity (Docherty et al., 1996; Mohapatra and Nau, 2005; Zhang et al., 2008) . Similarly, Ca 2+ dependent stimulation of PLC may pro mote cleavage of the sensitizing agent phosphatidylino sitol4,5bisphosphate (PIP 2 ) (Liu et al., 2005; Stein et al., 2006; Lishko et al., 2007; Lukacs et al., 2007; Yao and Qin, 2009; Mercado et al., 2010) . Although depletion of PIP 2 is thought to play a major role in desensitization (Lukacs et al., 2007; Mercado et al., 2010) , artificial de pletion of PIP 2 does not completely reproduce the near full desensitization observed in the presence of calcium (Lukacs et al., 2007) .
A third proposed mechanism is the inactivation of TRPV1 via interactions with Ca 2+ -calmodulin (CaM) (Numazaki et al., 2003; Rosenbaum et al., 2004; Lishko et al., 2007; Grycova et al., 2008) . CaM is a ubiquitous and highly conserved 17kD protein. It comprises two globular domains, the N and Clobes, connected by a central flexible linker that allows CaM to assume differ ent conformations (Barbato et al., 1992; Tjandra et al., 1995) . Each lobe contains two helixloophelix Ca 2+ binding motifs known as EF hands and can thus bind four Ca 2+ ions (Vetter and Leclerc, 2003) . Apo-CaM and Ca
2+
-CaM interact differently with many proteins including ion channels (GordonShaag et al., 2008) , making them versatile modulators of various proteins. CaM exhibits diverse mechanisms, sometimes acting through multiple sites, as shown for several TRP chan nels (Zhu, 2005) ; its target recognition mechanisms are nearly as promiscuous as its functions (Hoeflich and Ikura, 2002; Yamniuk and Vogel, 2004) .
Although TRPV1 does not have a recognizable CaM binding motif (Rhoads and Friedberg, 1997) , at least two CaMbinding sites have been identified in TRPV1 cytosolic domains. In vitro studies demonstrated that Ca 2+ -CaM binds isolated TRPV1 peptides from the TRPV1ARD (Rosenbaum et al., 2004) . In addition, Ca 2+ -CaM competes for a shared binding site on TRPV1 ARD with ATP, which sensitizes the channel to capsa icin and prevents tachyphylaxis . A second CaMbinding site was localized to a short 35resi due segment in the C terminus of TRPV1 (TRPV1CT) through in vitro binding assays (Numazaki et al., 2003) . Deletion of this segment disrupts desensitization of TRPV1 to repeated stimulation by capsaicin. Further more, several mutations to positively charged residues supplemented with 1× protease inhibitor and either 4 mM EDTA or 2 mM CaCl 2 ) was added. After a 2h incubation, beads were washed five times with 1 ml of the respective buffers and eluted in 80 µl of 2× SDS sample buffer supplemented with 10 mM EGTA.
Tryptophan fluorescence
Fluorescence experiments were performed using a fluorescence spectrophotometer (Cary Eclipse; Agilent Technologies) at room temperature, in 10 mM TrisHCl, pH 7.5, and 100 mM KCl, with 1 mM CaCl 2 or 5 mM EDTA. Tryptophan excitation was set to 295 nm to minimize contributions of CaM tyrosines to the emission spectra. Emission spectra were recorded from 305 to 400 nm. Ex citation and emission bandwidths were set at 5 nm. For intrinsic Trp fluorescence measurements of TRPV1CT44, 10mm path length cuvettes and a 1ml volume were used to measure 10 µM TRPV1CT44 alone or with 10 µM CaM in the presence of CaCl 2 or EDTA. For K d determination, a 5mm pathlength quartz cu vette (1 ml volume) was used. TRPV1CT44 at 0.1 µM in 1 ml was titrated with CaM from stocks of 0.04-1 mM, such that the final added volume was <2% of total volume. Fluorescence intensity at 330 nm was monitored, and results from three replicates were analyzed using one sitespecific binding nonlinear regression analysis (Prism 5; GraphPad). Nonspecific binding from titrations of TRPV1CT44 with CaM in EDTA was subtracted from total binding from the same titrations in CaCl 2 .
Size-exclusion chromatography (SEC) of TRPV1-ARD-CaM interactions SEC runs were performed as described previously . In brief, 60 µM of TRPV1ARD and 60 µM of CaM or CaM mutants were preincubated in running buffer (20 mM HEPES, pH 7.4, 140 mM NaCl, 1 mM DTT, and 0.16 mM CaCl 2 ) for 30 min on ice, followed by separation on a Superdex 75 column (GE Healthcare) at 4°C.
Disulfide cross-linked Ca
2+
-CaM/V1-CT35 mutants Possible disulfide bonds between Ca 2+ -CaM and TRPV1CT35 were predicted (CaM A15 /V1CT35 N789 and CaM E127 /V1CT35 R785 ) based on CC distances using the SSBOND program (Hazes and Dijkstra, 1988) . Both pairs were generated by mutagenesis, and all four resulting constructs were purified as above. To test crosslinking, 20 µg CaM E127C or CaM A15C alone or with TRPV1 CT35 R785C or TRPV1CT35 N789C , respectively, was mixed in 20 mM TrisHCl, pH 7.5, 100 mM NaCl, and 1 mM CaCl 2 , and incubated on ice for 20 min. DTT (10 mM final) or CuSO 4 1,10 phenanthro line (1-4 mM final) was added and incubated for an additional 20 min. Samples were resolved on 16% T 3% C Tricine SDSPAGE with 4% T 3% C stacking gel as described previously (Schägger, 2006) , in either reducing or nonreducing sample buffers, using running buffer supplemented with 1 mM CaCl 2 .
For purification of CaM E127C /V1CT35 R785C , CaM E127C and TRPV1CT35 R785C were mixed at a 1:1.5 ratio in 20 mM TrisHCl, pH 7.5, 100 mM NaCl, and 1 mM CaCl 2 , and 1-4 mM CuSO 4 1,10 phenanthroline was added after 20 min, with an additional 20min incubation on ice. For purification of CaM A15C /V1CT35 N789C , CaM A15C and TRPV1CT35 N789C were mixed at a 1:2 ratio in 20 mM TrisHCl, pH 7.5, 100 mM NaCl, 2 mM CaCl 2 , 3 mM GSH, and 0.3 mM GSSG and incubated at room temperature overnight. Crosslinked samples were dialyzed in 20 mM TrisHCl, pH 7.5, 100 mM NaCl, and 1 mM CaCl 2 and purified on a Superdex 75 (GE healthcare) column.
Electrophysiology
Whole cell patchclamping recordings were performed in HEK293 cells transiently transfected using Lipofectamine and PLUS reagent (Invitrogen). Currents were recorded 24-36 h after transfection in voltageramp experiments as described previously CaM A15C , and CaM E127C were purified as CaM. MBPTRPV1CT44 or CT35 was expressed in BL21(DE3) induced at OD 600 = 0.6 with 100 µM IPTG at 37°C for 2 h. Cells were lysed by sonication in buffer A (20 mM TrisHCl, pH 7.5, 200 mM NaCl, 0.5 mM PMSF, and 1 mM benzamidine) with 0.1% Triton X100, 40 µg/ml DNase, 80 µg/ml RNase, and 200 µg/ml lysozyme. The cleared lysate was diluted at 1:1 with buffer A supplemented with 2 mM CaCl 2 , loaded onto amylose resin (New England Biolabs, Inc.), washed with buffer B (20 mM Tris, pH 7.5, 200 mM NaCl, 1 mM DTT, and 1 mM CaCl 2 ) plus 0.5 mM PMSF, and eluted with buffer B plus 10 mM maltose. To obtain TRPV1CT44/35, MBPTRPV1CT44/35 was concentrated and cleaved with PreScission protease over night at 4°C. TRPV1CT44/35 was purified on a Superdex 75 (GE Healthcare) in 20 mM Tris, pH 7.5, 50 mM NaCl, and 1 mM DTT, concentrated, and stored at 80°C. Preparation of MBPTRPV1 CT35 for binding assays was as above with slight modifications: (a) CaCl 2 was excluded from all buffers; (b) 1 mM EDTA was added to lysis buffer; and (c) additional wash with buffer C (20 mM Tris, pH 7.5, 25 mM NaCl, and 1 mM DTT) and 1 mM PMSF was done before elution with buffer C and 10 mM maltose.
To obtain Ca
2+
CaM-TRPV1CT44/35 complex, CaM and excess TRPV1CT44/35 (1:1.25-2.0 molar ratio) were incubated in 20 mM Tris, pH 7.5, 200 mM NaCl, and 0.15 mM CaCl 2 . Ca 2+ CaM-TRPV1 CT44 complex was isolated on Superdex 75 (GE Healthcare).
Structure determination Crystals of Ca
2+
CaM-TRPV1CT35 (mixed at a 1.3:1 ratio at 8 mg/ml in 20 mM TrisHCl, pH 7.5, 100 mM NaCl, 1 mM CaCl 2 , and 1 mM DTT) were grown by vapor diffusion at room tempera ture against reservoir solution (0.1 M MES, pH 6.0, and 2.2-2.8 M (NH 4 ) 2 SO 4 ), transferred into reservoir plus 25% glycerol, and flashcooled in liquid nitrogen. Crystals of the two disulfide cross linked complexes were grown in very similar conditions. Diffrac tion data, collected at beamlines 24IDC and E (Advanced Photon Source, Argonne National Laboratory) at 0.97949 Å, were processed using HKL2000 (Otwinowski and Minor, 1997) . The structure was determined by molecular replacement using CaM coordinates of Protein Data Bank accession number 3DVE (Kim et al., 2008 ) as a search model. Model building was performed using COOT (Emsley and Cowtan, 2004) , and restrained TLS re finement was performed using REFMAC5 (Murshudov et al., 1997) . The final wildtype model includes CaM residues 3-148 and TRPV1CT35 residues 784-798 (deposited in the Protein Data Bank under accession no. 3SUI), with 93% of residues in most favored, 7% in allowed, and none in disallowed regions of the Ramachandran plot. Data and refinement statistics are shown in Table 1 and Table S1 .
Binding assays
For CaMagarose binding of MBPtagged TRPV1CT peptide, 60 µg MBPTRPV1CT35 in 500 µl of binding buffer (20 mM TrisHCl, pH 7.5, 100 mM NaCl, 0.1% TWEEN20, and 1 mM DTT) supple mented with either 1 mM EGTA or 1 mM CaCl 2 was incubated with preequilibrated CaMagarose (100 µl of 50% slurry; SigmaAldrich) at 4°C for 1 h. Beads were washed three times with 1 ml of the re spective binding buffers and resuspended in sample dye plus 5 mM EGTA, and bound protein was analyzed by SDSPAGE.
For CaMagarose binding of FLAGtagged TRPV1, HEK293 cells were transiently transfected with the pCDNA3FLAG-based vectors using Lipofectamine 2000 (Invitrogen). Cells were har vested in TNE buffer (10 mM TrisHCl, pH 7.5, 150 mM NaCl, and 1 mM EDTA) 30-40 h after transfection, collected by cen trifugation at 2,000 g, and lysed in 1 ml TNE buffer supplemented with 1× Complete protease inhibitor (Roche) and 1% IGEPAL (SigmaAldrich). The detergentsoluble fraction was divided into two fractions, adding EDTA to 4 mM to one and CaCl 2 to 2 mM to the second. CaMagarose (100 µl of 50% slurry in TNE buffer A short 35residue segment (residues 767-801) was iden tified as a CaMbinding site in TRPV1CT (Numazaki et al., 2003) . In the same study, a longer 44residue seg ment (residues 759-802) spanning this site was observed to bind CaM in the absence or presence of Ca 2+ in a GST pulldown assay. We used SEC to evaluate the interaction of CaM to the 44residue segment (TRPV1CT44) and the 35residue segment (TRPV1CT35; Fig. 1 A) . TRPV1 CT44 and TRPV1CT35 undergo a large shift in elution volume when mixed with CaM in the presence of Ca 2+ , confirming that a complex is formed (Figs. 1 B and S1; data shown for TRPV1CT44).
To obtain a quantitative measurement of Ca
2+
-CaM binding to TRPV1CT, we took advantage of the intrin sic tryptophan present in TRPV1CT peptides to moni tor its binding to Ca 2+ -CaM. We used TRPV1CT44, which is more readily produced in large quantities and high purity than TRPV1CT35. The fluorescence emis sion peak of tryptophan in TRPV1CT44 is 354 nm (Fig. 1 C) . In the presence of CaM in CaCl 2 but not EDTA, the fluorescence emission peak blueshifted to 330 nm and fluorescence intensity was enhanced, con sistent with a tryptophan residue in a hydrophobic en vironment (Gomes et al., 2000; Weljie and Vogel, 2000) . or in voltageclamp experiments at a holding potential of 60 mV. Standard bath solution contained 10 mM HEPES, pH 7.4, 150 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , and 10 mM glucose. Intracellular solution contained 10 mM HEPESCsOH, pH 7.2, 140 mM Csmethanesulfonate, 10 mM EGTA, and 2.5 mM NaCl.
Surface biotinylation assay
Transfected HEK293 cells were rinsed twice with icecold PBS, pH 8.0, and incubated with 0.5 mg/ml sulfoNHSBiotin (Thermo Fisher Scientific) in PBS, pH 8.0, for 30 min at 4°C. Cells were rinsed twice with cold 100 mM glycine in PBS and three times with PBS, lysed in 1 ml of RIPA buffer (50 mM TrisHCl, pH 7.5, 150 mM NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM EDTA, and 1× protease inhibitor cocktail from Roche), for 1 h at 4°C. Cleared lysates normalized for total protein concentration were incubated with 50 µl of 50% streptavidinagarose slurry (SigmaAldrich) for 1 h at 4°C. The beads were washed three times with RIPA buffer and eluted with 50 µl of 2× SDS sample buffer. Table S1 contains data and refinement statistics for the two cross linked Ca 2+ CaM-TRPV1CT35 crystal structures. Fig. S1 shows for mation of the Ca 2+ CaM-TRPV1CT44 complex by SEC. Fig. S2 shows CaMagarose pulldown assay results for several TRPV1CT35 mutants. Fig. S3 shows SEC traces of experiments with rat TRPV1 ARD and CaM mutants. Fig. S4 shows SEC traces probing a possible ternary interaction between TRPV1ARD, CaM, and TRPV1CT. ( Fig. 2 A and CaM-TRPV1CT35 complex. Residues 784-798 of TRPV1CT were observed in the structure (Fig. 2 A) , with the electron density well defined for residues 785-797 (Fig. 2 , B and C). As expected, four Ca 2+ ions are observed in the structure, with two in each CaM lobe. TRPV1CT35 adopts an elongated structure, with a helix (residues 787-796) flanked by two extended peptide regions (Fig. 2 A) . The helical peptide is clasped by both Ca 2+ -CaM lobes in an antiparallel orientation, with its N terminus interacting with the Ca 2+ -CaM Clobe and its C terminus bound to the Nlobe. This overall Ca 2+ CaM-TRPV1CT35 structure is simi lar to several canonical Ca 2+ -CaM peptide complexes (Yamniuk and Vogel, 2004) , including those of smooth muscle light chain kinase (Meador et al., 1992) , Ca 2+ -CaMdependent kinase kinase (CaMKK) (Kurokawa et al., 2001) , and endothelial nitric oxide synthase (Aoyagi et al., 2003) .
Online supplemental material
TRPV1-CT target recognition and binding by Ca
2+ -CaM
In canonical Ca 2+ -CaM peptide complexes, the peptide is anchored through interactions of two large hydro phobic residues to hydrophobic pockets, one on each Ca 2+ -CaM lobe (Fig. 3 A) . The relative sequence posi tion of the anchor residues defines the binding mode of Ca 2+ CaM-peptide complexes. TRPV1CT35 is indeed anchored to hydrophobic pockets on the C and Nlobes of Ca 2+ -CaM through hydrophobic anchor residues W787 and L796 at the C and Nlobe, respectively (Fig. 3 B) .
Our results further confirm that TRPV1CT interacts with CaM in a Ca 2+ dependent manner. In a titration experiment, we measured that TRPV1CT44 interacts with Ca 2+ -CaM in a 1:1 ratio with high affinity, K d = 5.4 ± 0.6 × 10 8 M (Fig. 1 D) , comparable to other Ca 2+ -CaM binding targets (Crivici and Ikura, 1995) . Our results establish the distal TRPV1CT region as a high affinity binding site for Ca 2+ -CaM.
Overall structure of Ca 2+ -CaM-TRPV1-CT peptide complex TRPV1 does not have a classical CaM recognition motif (Rhoads and Friedberg, 1997) . To better understand the Ca 2+ -CaM interaction with TRPV1CT, we deter mined the crystal structure of Ca 2+ -CaM in complex with TRPV1CT35 (residues 767-801) to 1.95Å resolution contacts with the highly acidic surface of CaM and can drive the orientation of the bound CaM target (Osawa et al., 1999; Yamniuk and Vogel, 2004) . Antiparallel Ca 2+ -CaM targets have positive residues near the Nterminal anchor, whereas in the case of parallel Ca 2+ -CaM targets, basic residues flank the CT anchor (Fig. 3 A) . This preferential distribution of basic residues around one anchor or the other in an antiparallel or parallel target can be understood from examining the comple mentary electrostatic surfaces on Ca 2+ -CaM, which are important in determining the orientation of the bound peptide (Osawa et al., 1999) . In our structure, basic resi dues R785 and K788 flank the Nterminal hydrophobic anchor W787 near the highly electronegative opening in the Ca 2+ -CaM structure, whereas the single CT basic residue, R797, is oriented toward the less electronega tive opening (Fig. 4 A) . In summary, although no canoni cal CaMbinding sequence is found in the TRPV1CT, TRPV1CT35 therefore has a 1-10 motif like that of CaMdependent kinase II (Meador et al., 1993) .
The Nterminal anchor, W787, forms extensive hy drophobic contacts with surrounding residues F92, L105, M124, and M144, lining a deep hydrophobic pocket in the Ca 2+ -CaM Clobe (Fig. 3 B) . These four residues form the FLMM C tetrad, which is conserved in its interaction with its target anchor, whereas the FLMM N tetrad in the Nlobe (F19, L32, M51, and M71) is more variable (Ataman et al., 2007) . The TRPV1CT anchor, L796, contacts F19, M51, and M71 from the FLMM N tetrad (Fig. 3 B) . In addition to the anchor resi dues, other hydrophobic residues along the TRPV1 CT35  helix, namely F790, A791, L792, V793, P794, and L795, also form extensive hydrophobic contacts with both the N and Clobes of Ca 2+ -CaM (Fig. 3 D) . Although hydrophobic residues are major determinants of CaM interactions, basic residues mediate electrostatic -CaMbinding peptides with antiparallel 1-10 motifs (TRPV1CT and CaMKIIa; Meador et al., 1993 ) and 1-14 motifs (smooth muscle light chain kinase [Meador et al., 1992] , skMLCK , and CaMKI [Clapperton et al., 2002] ), and parallel 1-16 motifs (CaMKK [Osawa et al., 1999] and cCAMKKp [Kurokawa et al., 2001] ) of calcium is shown as a representative result of three independent experiments. An MBP- Gal protein construct, expressed from the unmodified vector, was used as a negative control. (D) Sequence map of CaM residues in contact with TRPV1CT35 (interatomic distances of ≤4.2 Å). CaM Nlobe, Clobe, and TRPV1CT35 residues are mustard, orange, and cyan, respectively. Interacting CaM residues making at least one polar contact are boxed.
Both hydrophobic and positively charged residues are important determinants of binding Interestingly, the Ca 2+ -CaMbinding site observed in our crystal structure overlaps a previously proposed PIP 2 binding site required for PIP 2 mediated inhibition of TRPV1 activity (Prescott and Julius, 2003) , although this study's conclusions are controversial (see Discus sion). In the study, substitution of several basic residues by neutral polar residues resulted in increased sensitiv ity of TRPV1 to both chemical and heat stimuli. This phenotype was interpreted as a relief of inhibitory PIP 2 interactions with TRPV1. In particular, the R785Q/ K788Q substitution pair increased TRPV1 sensitivity to heat by shifting the temperature threshold of activation to lower temperatures. Incidentally, R785 and K788 are the two basic residues that flank the hydrophobic tryp tophan anchor in our Ca 2+ -CaMbinding site (Fig. 3 A) CaM-TRPV1CT35 complex exhibits several unique features. The first is the structure of the TRPV1 CT peptide, which consists of a short 10residue helix flanked by two extended peptide regions (Fig. 2 A) , unlike classical Ca 2+ -CaM targets that assume longer helical structures (Rhoads and Friedberg, 1997; Yamniuk and Vogel, 2004 (Osawa et al., 1999) . The MARCKS and TRPV1CT peptides share the same antiparallel orientation with respect to Ca A second feature unique to TRPV1CT is that the two hydrophobic anchors are at the boundaries of the helical region (Fig. 4 B) , whereas those of clas sical Ca 2+ -CaM targets are present within the  helix. Out of the nearly 40 available Ca 2+ CaM-peptide complex structures that we analyzed, the only Ca 2+ -CaM target that also carries a nonhelical hydro phobic anchor is the CaMKK peptide. However, the binding modes of CaMKK and TRPV1CT are differ ent in all other aspects. The CaMKK peptide exhibits a parallel 1-16 binding mode, with an Nterminal tryptophan hydrophobic anchor on the  helix and its CT anchor, a phenylalanine residue, on the ex tended CT region (Osawa et al., 1999) . In summary, the structure of the Ca 2+ CaM-TRPV1CT complex revealed yet another variation of Ca 2+ -CaM target recognition motifs, with a 1-10 antiparallel binding mode in which both hydrophobic anchors bound the peptide helix. -CaM (top) viewed from N (left) and CT (right) face of equivalently positioned TRPV1CT peptide (bottom). The molecular surface is colored according to the electrostatic potential from red (6 kT/e) to blue (6 kT/e). Electrostatic potential surfaces were generated in PyMOL using APBS (Baker et al., 2001) TRPV1CT35 to Ca 2+ -CaM in our pulldown assay (Fig. S2) , the L792P substitution severely disrupted Ca 2+ -CaM bind ing (Fig. 3 C) . A proline substitution at L792, which is situated in the middle of the TRPV1CT35 helix in the Ca 2+ -CaMbound structure, would break the helical con formation of the peptide and thus likely displace other necessary Ca 2+ -CaM interacting groups. In contrast, the L796P substitution is located at the CT end of the helix, providing a likely explanation as to why this mutation is tolerated. Our binding assay agrees well with the observed Ca 2+ CaM-TRPV1CT structural features. To examine whether phosphorylation of S800, which potentiates TRPV1 (Bhave et al., 2003) , interferes with Ca 2+ -CaM binding, we mutated S800 to either an aspar tic acid or glutamic acid to mimic a phosphorylation state. Neither S800D nor S800E interfered with Ca 2+ -CaM binding (Fig. S3) . This result is consistent with our structural data, as S800 lies outside the region observed in our structure (Fig. 3 D) and suggests that disruption of Ca 2+ -CaM binding is not the cause of the observed phosphorylationinduced potentiation in TRPV1.
Collectively, our mutagenesis results confirmed that TRPV1CT35 interacts extensively with Ca 2+ -CaM through both hydrophobic and electrostatic interactions (Fig. 3 D) .
spots responsible for the bulk of binding energy (Bogan and Thorn, 1998) , and as anticipated, substitution of the hydrophobic anchor W787 with alanine caused a severe disruption of Ca 2+ -CaM binding, underscoring the importance of the tryptophan anchor in mediating hydrophobic interactions with Ca 2+ -CaM (Fig. 3 C) . Al anine substitutions at the R785/K788 pair also impaired Ca 2+ -CaM binding, indicating that these basic residues are likewise crucial for interaction with Ca 2+ -CaM (Fig. 3 C) , consistent with a previously published study (Grycova et al., 2008) . Chargeneutralizing R785Q/K788Q sub s titutions, which were previously shown to potentiate TRPV1 activity (Prescott and Julius, 2003) , also impair binding to Ca 2+ -CaM (Fig. 3 C) . A separate study aimed at identifying active or hyper sensitive TRPV1 mutants using a toxicitybased screen (Myers et al., 2008) identified several mutations that fell within our Ca 2+ -CaMbinding site: W787R, L792P, and L796P. To determine whether these mutations alter Ca 2+ -CaM binding, we studied the interaction of these mutants using our CaMagarose pulldown assay. As with W787A, W787R severely disrupted Ca 2+ -CaM binding (Fig. 3 C) . Although mutation of the L796 CT anchor to proline did not significantly disrupt binding of -CaM Clobe appears to dominate the interactions of both TRPV1CT and TRPV1ARD, it remained to be determined whether we could observe a ternary complex between TRPV1ARD, a TRPV1CT peptide, and Ca 2+ -CaM. Using SEC, a shift of the rat TRPV1ARD peak was observed in the presence of iso lated Ca 2+ CaM-TRPV1CT44 complex (Fig. S4) . How ever, we could not unambiguously ascertain whether the observed TRPV1ARD shift was caused by its interac tion with a Ca CaM-TRPV1CT peptide complex. Two cysteine pairs were engineered based on pre dicted optimal disulfide bond sites using SSBOND (Hazes and Dijkstra, 1988 ): TRPV1CT35 N789C cross links to A15C in the Nlobe of Ca 2+ -CaM, and TRPV1 CT35 R785C crosslinks to E127C in the Ca 2+ -CaM Clobe (Fig. 6 A) . Both sets of mutants display a Ca 2+ dependent interaction similar to wildtype Ca 2+ -CaM and TRPV1CT35, as shown in native gel (Fig. 6 B) . Al though the E127C-R785C pair crosslinked more effi ciently under our original conditions (Fig. 6 C) , we were able to isolate both crosslinked complexes with good purity (see Materials and methods). Both crosslinked complexes crystallized under very similar conditions and in the same space group as the wildtype complex, and we determined the Ca 2+ CaM E127C -TRPV1CT35 R785C structure to 2.4Å resolution, and the Ca 2+ CaM A15C -TRPV1CT35 N789C to 2.1Å resolution. Both structures exhibited only minimal local conformational variations (Fig. S5) . Thus, the introduced crosslinks in the Ca 2+ CaM-TRPV1CT peptide complex did not perturb the interactions observed in our original structure.
We then used SEC to investigate whether the cross linked complexes interact with rat TRPV1ARD. Neither TRPV1ARD nor the crosslinked complexes showed a shift in elution volume when incubated together ( Fig. 6 D) ; therefore, the SEC profiles showed no evidence of inter action between TRPV1ARD and either crosslinked com plex. Although we cannot rule out the possibility that crosslinking may interfere with possible conformational requirements for interaction with the TRPV1ARD, the fact that neither Ca 2+ CaM E127C -TRPV1CT35 R785C nor Ca 2+ CaM A15C -TRPV1CT35 N789C interacted with TRPV1ARD makes it unlikely that the crosslink itself prevented the interaction. Our results therefore indicate that TRPV1 ARD and TRPV1CT do not form a ternary complex with Ca 2+ -CaM under the conditions we tested.
Notably, mutation of the Nterminal tryptophan anchor alone is sufficient to severely diminish Ca 2+ -CaM inter action, suggesting that the Clobe of Ca 2+ -CaM domi nates the interactions with TRPV1CT35.
CaM C-lobe alone is sufficient to interact with TRPV1-ARD The interactions of Ca 2+ -CaM with both TRPV1ARD and TRPV1CT are Ca 2+ dependent and both regions have been implicated in TRPV1 desensitization, sug gesting that both sites may work in concert. One hypoth esis is that Ca 2+ -CaM bridges an interaction between the TRPV1ARD and TRPV1CT, leading to a closed chan nel . CaM forms an analogous ter nary complex in SK channels, for example, where CaM mediates dimerization of two channel subunits through binding of its N and Clobe to two different subunits (Schumacher et al., 2001) . Having determined that the Clobe dominates the TRPV1CT35 interaction, we asked whether the TRPV1ARD is similarly dominated by a specific CaM lobe.
We have been unable to measure the affinity of TRPV1 ARD for Ca 2+ -CaM because of technical difficulties with protein stability under various assay conditions, or to cocrystallize a Ca 2+ CaM-TRPV1ARD complex to de termine its structure. Instead, we tested which CaM lobe principally drives the Ca 2+ dependent interaction with TRPV1ARD by using SEC to compare the impact of mu tations at the CaM Ca 2+ binding sites on the interaction. CaM1, CaM2, CaM3, and CaM4 were mutated at the first (D21A), second (D57A), third (D94A), or fourth (D130A) Ca 2+ binding site, respectively. Rat TRPV1ARD no longer interacted with any of the singlesite CaM mu tants (Fig. S3) . However, rat TRPV1ARD exhibits only a small shift by SEC when mixed with Ca 2+ -CaM, perhaps because of a weak interaction that is highly susceptible to perturbations. Slight differences in affinities for the distinct CaM mutants would be missed if any perturba tion caused a loss of detectable binding. Therefore, we also tested interactions between the CaM mutants and chicken TRPV1ARD, which in SEC experiments has a robust shift with wildtype Ca 2+ -CaM (Fig. 5 A) . Chicken TRPV1ARD showed no interaction with CaM1234, which has all four Ca 2+ binding sites mutated (Fig. 5 B) , demonstrating that the interaction with CaM is Ca 2+ de pendent. Chicken TRPV1ARD retained the ability to interact with CaM12 but not CaM34 (Fig. 5, C and D) , pointing to the importance of Ca 2+ -CaM Clobe in inter acting with TRPV1ARD. Using a truncated CaM (res idues 76-148), we further showed that the isolated Ca 2+ -CaM Clobe can bind TRPV1ARD (Fig. 5 E) . Al though chicken and rat TRPV1ARD may interact differ ently with Ca 2+ -CaM, their close homology (69.5% identity and 82.0% similarity) suggests that they likely share a common binding mode . Thus, our results suggest that the Ca 2+ -CaM Clobe is crucial for binding to TRPV1ARD. . To examine the functional role of the high affinity TRPV1CT Ca 2+ -CaMbinding site, we intro duced mutations that abolish Ca 2+ -CaM binding to either TRPV1ARD (K155A), TRPV1CT (W787A), or both TRPV1ARD and TRPV1CT (K155A/W787A) and compared the capsaicinevoked currents in HEK293 cells. We measured the maximal current amplitude evoked by each successive pulse of capsaicin using the whole cell patchclamp technique in voltage ramps (Fig. 8) or at a holding potential of 60 mV (Fig. S6) . As expected, repeated applications of capsaicin resulted in strong tachyphylaxis of wildtype TRPV1 currents, -CaM binding to TRPV1ARD and TRPV1CT (this study), respectively, and determined whether the resulting TRPV1 mutants can still bind Ca 2+ -CaM using a CaMagarose pulldown assay. Wildtype TRPV1 expressed from HEK293 cells binds CaM in a Ca 2+ dependent manner (Fig. 7 A) -CaM (gray) with modeled disulfide bonds (pink) based on predictions using SSBOND (Hazes and Dijkstra, 1988) . (B) NativePAGE of CaM or CaM cysteine mutants alone or in the presence of increasing molar ratio of respective TRPV1CT or TRPV1CT mutant. (C) Tricine-SDSPAGE of CaM and TRPV1CT35 cysteine mutants under reducing or oxidizing conditions. (D) 60 µM of purified rat TRPV1ARD (RnARD) was mixed with 60 µM CaM (left), 60 µM of the crosslinked complex CaM E127C -V1CT35 R785C (middle), or 60 µM CaM A15C -V1CT35 N789C (right) in the presence of CaCl 2 and separated using SEC.
in capsaicininduced desensitization but may be involved in other responses not discernible under our experi mental conditions.
D I S C U S S I O N
Here, we present the structure of Ca 2+ -CaM bound to a short 35residue TRPV1CT region (TRPV1CT35), one of two identified Ca 2+ -CaMbinding sites in TRPV1. The second Ca 2+ -CaMbinding site was previously identified in TRPV1ARD (Rosenbaum et al., 2004) , where Ca 2+ -CaM competes with a TRPV1 sensitizer, ATP, for binding . Our affinity measurements indicate that TRPV1CT represents a high affinity binding site for Ca 2+ -CaM (K d = 5.4 ± 0.6 × 10 8 M). Although we could not measure the affinity of TRPV1ARD for Ca 2+ -CaM because of technical difficulties, our SEC experiments suggest that the affinity is likely significantly lower than that of the TRPV1CT. Consistently, a mutation that abol ished Ca 2+ -CaM binding to TRPV1CT (W787A), but not a corresponding one in TRPV1ARD (K155A), severely disrupted binding to Ca 2+ -CaM in fulllength TRPV1. The W787A mutation was sufficient to slow and reduce TRPV1 desensitization, consistent with a 35-amino acid deletion mutant that also exhibited reduced Ca 2+ depen dent desensitization of TRPV1 (Numazaki et al., 2003) .
The interaction of Ca 2+ -CaM with TRPV1CT35 is similar to that observed in canonical Ca 2+ -CaM/target complexes. The bound peptide adopts an helical con formation and binds Ca 2+ -CaM in an antiparallel man ner through two hydrophobic anchors, W787 and L796, corresponding to a 1-10 binding motif. Sequence align ment of the TRPV1CT CaMbinding site identified in the rat TRPV1 sequence with TRPV1 from other species shows that this site is conserved (Fig. 7 B) , suggesting a conserved function. observed as decreased inward currents (Fig. 8 A, black  trace) . K155A showed little tachyphylaxis and slower ac tivation kinetics as reported previously . The slower activation kinetics of K155A is not caused by altered surface expression (Fig. S6) and is therefore an inherent quality of the mutant. Although the slower activation kinetics could suggest a constitu tively desensitized phenotype, the steadystate inward currents of K155A are larger than those of wild type (Fig. 8 C) . Furthermore, it has been reported that desensitization reduces the sensitivity of TRPV1 to cap saicin (Yao and Qin, 2009 ), whereas we previously deter mined that the K155A mutant displays normal capsaicin sensitivity .
In contrast, the W787A mutant showed desensitiza tion albeit with slower kinetics and significantly higher residual currents in subsequent capsaicin application compared with wildtype TRPV1. As most tachyphy laxis occurs between the first and second application (Mohapatra et al., 2003) , we compared the mean maximal current amplitude at 80 mV of the second applica tion to that of the first application. Wildtype TRPV1 expressing cells only retained 2.3 ± 0.4% of their maximal current at the second application, whereas W787A expressing cells retained 14.4 ± 3.2% (n = 8 and P = 0.006). Our results with the W787A mutation are simi lar to those obtained when the TRPV1CT35 region is deleted in fulllength TRPV1 (Numazaki et al., 2003) , showing that TRPV1CT is indeed involved in the fast component of TRPV1 desensitization. Disruption of both Ca 2+ -CaMbinding sites (K155A/W787A) led to capsaicininduced currents similar to the K155A muta tion. In summary, the stronger phenotype elicited by K155A suggests a major role for TRPV1ARD in TRPV1 desensitization, whereas the more subtle W787A pheno type suggests that TRPV1CT plays a minor role -CaM. Detergentsoluble fractions of HEK293 cells expressing wildtype, K155A, or W787A FLAGtagged TRPV1 were incubated with CaMagarose beads in the presence of EDTA or CaCl 2 and washed, and the bound fractions were eluted and analyzed by Western blot using antiFLAG antibody. Shown is a representative result of three independent experiments. (B) Sequence alignment of the rat TRPV1 CT35 region with representative mammalian and avian species shows that the region is highly conserved (se quence identity over the whole protein sequence of rat TRPV1 vs. mouse, human, guinea pig, bovine, rabbit, chicken, and bat splice variants [long and short] TRPV1 is 96, 86, 89, 86, 87, 67, 86, and 87%, respectively) . Nonconserved residues are shaded gray. The region vis ible in the crystal structure (residues 784-798) and the helical region (788-796) are indicated above the align ment (cyan).
Ca
2+ -calmodulin interactions with TRPV1
The TRPV1CT Ca 2+ -CaMbinding site identified in our structure overlaps a region previously identified as an inhibitory PIP 2 binding domain, although no direct binding was demonstrated (Prescott and Julius, 2003) . A subsequent study found that the inhibitory effects of PIP 2 on TRPV1 were only detectable in whole cells, not excised patches, suggesting that PIP 2 mediated inhibi tion is indirect (Lukacs et al., 2007) . Furthermore, PIP 2 can also potentiate TRPV1 (Liu et al., 2005; Lishko et al., 2007; Lukacs et al., 2007) and does so through a proximal CT region (residues 682-725) (UfretVincenty et al., 2011) . Together with these findings on TRPV1 regulation by PIP 2 , our data support the distal CT re gion of TRPV1 as a physiologically important Ca 2+ -CaM binding site.
The interactions of Ca 2+ -CaM with both TRPV1ARD and TRPV1CT are implicated in TRPV1 desensitiza tion (Numazaki et al., 2003; Lishko et al., 2007) . This brings up the question of whether Ca 2+ -CaM regula tion of TRPV1 at TRPV1ARD and TRPV1CT constitutes integrated or separate mechanisms. Several findings suggested that both sites may work together in the de sensitization mechanism. First, mutations or deletion of the Ca 2+ -CaMbinding site either in TRPV1ARD or TRPV1CT disrupts desensitization (Numazaki et al., 2003; Lishko et al., 2007) . Second, a toxicitybased screen for active or hypersensitive TRPV1 phenotype (Myers et al., 2008) identified mutations that impair Ca 2+ -CaM binding in either TRPV1ARD, such as K155E/A and K160E/A , or TRPV1CT, such as W787R and L792P (Fig. 3 C) . One hypothesis is that Ca 2+ -CaM may bridge an interaction between TRPV1ARD and TRPV1CT . A similar mechanism is postulated for CaM regula tion of voltagegated Ca v 1 channels (Dick et al., 2008) , and CaM bridges two subunits of a Ca 2+ activated K + chan nel (Schumacher et al., 2001 ). Here, we generated two different crosslinked Ca 2+ CaM-TRPV1CT complexes but did not observe any ternary assemblies of these crosslinked complexes with TRPV1ARD. This sug gests that the Ca 2+ -CaMmediated desensitization of TRPV1 may instead involve separate pathways. However, we cannot rule out the possibility that the introduced crosslinks, which maintain the interactions observed in the un-crosslinked complex (Fig. S5) , may restrict conformational changes required for interaction with TRPV1ARD.
We observed a more pronounced disruption of de sensitization in response to capsaicin when mutating the Nterminal K155A than the CT W787A, suggesting that the TRPV1ARD is most important for tachyphy laxis. Mutation of the CT site, on the other hand, led to a more subtle phenotype of slowed and reduced desen sitization (Fig. 8) . Notably, the CT site was most impor tant for Ca 2+ -CaM binding in our pulldown assays. Therefore, our data suggest that Ca 2+ -CaM binding may . Cells were repeatedly stimulated with 1 µM capsaicin for 1 min fol lowed by 1min washouts. The +80 mV (red) and 80 mV (black) currents extracted from 1,500ms voltage ramps are shown. (B) Mean current amplitudes for successive capsaicin applications were normalized to the maximal current amplitudes of the first capsaicin application. *, P < 0.01 versus TRPV1 wild type using twotailed unpaired t tests. (C) Mean current density of the maxi mal response to the first capsaicin application normalized to the cell capacitance. The values in B and C were calculated from cur rent amplitudes at 80 mV (negative scale) and +80 mV (posi tive scale) measured in experiments as in A. Bars represent mean ± SEM (n = 6, 8, 8, and 8 for wild type, W787A, K155A, and W787A/ K155A, respectively). not be the dominant regulatory factor for TRPV1 de sensitization. Overall, our data are consistent with a model where PIP 2 depletion is a major contributor to the acute desensitization of TRPV1 after activation by capsaicin (Lukacs et al., 2007; Mercado et al., 2010) , with Ca 2+ -CaM binding to the TRPV1CT likely playing a supporting role.
It is possible that the CT Ca
2+
-CaMbinding site plays a more important role in regulating other TRPV1 re sponses not tested in the current study. Several studies hint at a role of the TRPV1CT Ca 2+ -CaMbinding site in tuning channel sensitivity. Increased sensitivity to heat and/or hypersensitivity was observed in several CT mutants (Prescott and Julius, 2003; Myers et al., 2008) and in the vampire bat TRPV1S isoform in which the CTbinding site is absent (Gracheva et al., 2011) .
In summary, we showed that TRPV1CT represents a high affinity binding site for Ca 2+ -CaM. The TRPV1ARD and TRPV1CT likely provide two separate regulatory pathways, a model that is supported by both our bio chemical and electrophysiological analyses. Our work provides new biochemical and structural information that enables future studies to fully decipher the molecu lar mechanisms behind the physiological regulation of TRPV1 responses.
